Cite

HARVARD Citation

    Ge, X. et al. (2019). Midostaurin potentiates rituximab antitumor activity in Burkitt's lymphoma by inducing apoptosis. Cell death and disease. 10 (1), pp. 1-12. [Online]. 
  
Back to record